PE

Q4 2023 update: private equity deals in pharmaceutical in North America

In the North American pharmaceutical industry, there were 34 private equity deals announced in Q4 2023, worth a total value…

Q3 2023 update: immuno-oncology related private equity activity in the pharmaceutical industry

Analysis of the key themes driving private equity deal activity reveals that immuno-oncology accounted for 3 pharmaceutical deals announced in…

Q4 2023 update: private equity deals in pharmaceutical in Europe

In the European pharmaceutical industry, there were 21 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: private equity deals in pharmaceutical in Asia-Pacific

In the Asia-Pacific pharmaceutical industry, there were 10 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: private equity deals in pharmaceutical in India

In the Indian pharmaceutical industry, there were 3 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: private equity deals in pharmaceutical in the UK

In the British pharmaceutical industry, there were 6 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: private equity deals in pharmaceutical in the US

In the US pharmaceutical industry, there were 31 private equity deals announced in Q4 2023, worth a total value of…

Q4 2023 update: orphan designated drugs related private equity activity in the pharmaceutical industry

Analysis of the key themes driving private equity deal activity reveals that orphan designated drugs accounted for 5 pharmaceutical deals…

How did Private equity deals perform in pharmaceutical in Q4 2023?

In the global pharmaceutical industry, there were 66 private equity deals announced in Q4 2023, worth a total value of…

How smart hospitals private equity performed in the pharmaceutical industry in Q3 2023

Analysis of the key themes driving private equity deal activity reveals that smart hospitals accounted for 4 pharmaceutical deals announced…